Singapore's Cordlife Group buys 19.9% stake in Stemlife


KUALA LUMPUR: Singapore-listed Cordlife Group Ltd, which is a service provider of umbilical cord blood and tissue banking, has emerged as a major shareholder in Stemlife Bhd with a 19.92% stake.

A filing with Bursa Malaysia on Wednesday showed Cordlife had bought 49.30 million shares on Sept 3.

Win a prize this Mother's Day by subscribing to our annual plan now! T&C applies.

Monthly Plan

RM13.90/month

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
   

Next In Business News

Foreign inflow to Bursa Malaysia surges to RM1.06bil net
Domestic equities get boost from global demand
Trading ideas: BHIC, Naza, F&N, Pestech, PetGas, XIX, TT Vision, Uzma, WTK, Ranhill, Farm Price, Sarawak Cable, SLP
Fed’s Williams says 2% inflation target ‘critical’
TD risks earnings hit from US probe
Promoting Techcombank as industry leader
EV maker Zeekr set to raise US$368mil from IPO
EV production keeps demand for copper high
New tea businesses bubble up toward a boom
United, American strike deal on US$8.5bil Chicago O’Hare airport revamp

Others Also Read